S&P 500   4,583.81 (+0.76%)
DOW   36,106.04 (+0.14%)
QQQ   390.13 (+1.32%)
AAPL   194.75 (+1.26%)
MSFT   369.91 (+0.30%)
META   326.39 (+2.82%)
GOOGL   136.62 (+5.08%)
AMZN   147.09 (+1.78%)
TSLA   243.28 (+1.63%)
NVDA   463.21 (+1.80%)
NIO   7.49 (-3.35%)
BABA   72.22 (+1.02%)
AMD   125.34 (+7.29%)
T   17.04 (+0.59%)
F   10.82 (+1.22%)
MU   73.62 (+0.67%)
CGC   0.72 (+2.80%)
GE   118.75 (-0.88%)
DIS   92.76 (+1.38%)
AMC   6.83 (+0.59%)
PFE   28.81 (+0.07%)
PYPL   58.50 (-1.73%)
XOM   99.17 (+0.06%)
S&P 500   4,583.81 (+0.76%)
DOW   36,106.04 (+0.14%)
QQQ   390.13 (+1.32%)
AAPL   194.75 (+1.26%)
MSFT   369.91 (+0.30%)
META   326.39 (+2.82%)
GOOGL   136.62 (+5.08%)
AMZN   147.09 (+1.78%)
TSLA   243.28 (+1.63%)
NVDA   463.21 (+1.80%)
NIO   7.49 (-3.35%)
BABA   72.22 (+1.02%)
AMD   125.34 (+7.29%)
T   17.04 (+0.59%)
F   10.82 (+1.22%)
MU   73.62 (+0.67%)
CGC   0.72 (+2.80%)
GE   118.75 (-0.88%)
DIS   92.76 (+1.38%)
AMC   6.83 (+0.59%)
PFE   28.81 (+0.07%)
PYPL   58.50 (-1.73%)
XOM   99.17 (+0.06%)
S&P 500   4,583.81 (+0.76%)
DOW   36,106.04 (+0.14%)
QQQ   390.13 (+1.32%)
AAPL   194.75 (+1.26%)
MSFT   369.91 (+0.30%)
META   326.39 (+2.82%)
GOOGL   136.62 (+5.08%)
AMZN   147.09 (+1.78%)
TSLA   243.28 (+1.63%)
NVDA   463.21 (+1.80%)
NIO   7.49 (-3.35%)
BABA   72.22 (+1.02%)
AMD   125.34 (+7.29%)
T   17.04 (+0.59%)
F   10.82 (+1.22%)
MU   73.62 (+0.67%)
CGC   0.72 (+2.80%)
GE   118.75 (-0.88%)
DIS   92.76 (+1.38%)
AMC   6.83 (+0.59%)
PFE   28.81 (+0.07%)
PYPL   58.50 (-1.73%)
XOM   99.17 (+0.06%)
S&P 500   4,583.81 (+0.76%)
DOW   36,106.04 (+0.14%)
QQQ   390.13 (+1.32%)
AAPL   194.75 (+1.26%)
MSFT   369.91 (+0.30%)
META   326.39 (+2.82%)
GOOGL   136.62 (+5.08%)
AMZN   147.09 (+1.78%)
TSLA   243.28 (+1.63%)
NVDA   463.21 (+1.80%)
NIO   7.49 (-3.35%)
BABA   72.22 (+1.02%)
AMD   125.34 (+7.29%)
T   17.04 (+0.59%)
F   10.82 (+1.22%)
MU   73.62 (+0.67%)
CGC   0.72 (+2.80%)
GE   118.75 (-0.88%)
DIS   92.76 (+1.38%)
AMC   6.83 (+0.59%)
PFE   28.81 (+0.07%)
PYPL   58.50 (-1.73%)
XOM   99.17 (+0.06%)

Beauty Health Stock Price, News & Analysis (NASDAQ:SKIN)

$3.03
+0.06 (+2.02%)
(As of 11:51 AM ET)
Compare
Today's Range
$2.95
$3.16
50-Day Range
$1.39
$6.02
52-Week Range
$1.35
$13.90
Volume
1.16 million shs
Average Volume
2.84 million shs
Market Capitalization
$397.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.38

Beauty Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
182.0% Upside
$8.38 Price Target
Short Interest
Healthy
27.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.98mentions of Beauty Health in the last 14 days
Based on 26 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.82) to ($0.04) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Medical Sector

187th out of 958 stocks

Surgical & Medical Instruments Industry

24th out of 78 stocks


SKIN stock logo

About Beauty Health Stock (NASDAQ:SKIN)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN Stock Price History

SKIN Stock News Headlines

Who owns Rare Beauty?
The Battery Metal Nobody Told You About
According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."
The Battery Metal Nobody Told You About
According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."
See More Headlines
Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SKIN
Fax
N/A
Employees
1,034
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.38
High Stock Price Target
$23.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+182.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
14 Analysts

Profitability

Net Income
$44.38 million
Pretax Margin
-22.45%

Debt

Sales & Book Value

Annual Sales
$399.30 million
Cash Flow
$0.56 per share
Book Value
$1.30 per share

Miscellaneous

Free Float
76,529,000
Market Cap
$389.86 million
Optionable
Optionable
Beta
0.81
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Daniel Copell Watson (Age 60)
    Chief Revenue Officer
    Comp: $777.36k
  • Mr. Michael P. Monahan (Age 51)
    Chief Financial Officer
  • Mr. Bradley Hauser (Age 46)
    Chief Operating Officer
  • Eduardo Rodriguez
    Senior Director of M&A and Investor Relations
  • Mr. Paul Bokota
    VP & General Counsel
  • Ms. Amy Juaristi
    Chief Marketing & Communications Officer
  • Ms. Celeste Ortiz
    Chief Human Resources Officer
  • Mr. Mingo Ku
    President of APAC
  • Mr. Jon Arnold
    President of EMEA
  • Mr. David S. Aquino
    Executive Vice President of Global Operations














SKIN Stock Analysis - Frequently Asked Questions

Should I buy or sell Beauty Health stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beauty Health in the last twelve months. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SKIN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SKIN, but not buy additional shares or sell existing shares.
View SKIN analyst ratings
or view top-rated stocks.

What is Beauty Health's stock price target for 2024?

14 analysts have issued 1 year price objectives for Beauty Health's stock. Their SKIN share price targets range from $2.00 to $23.00. On average, they predict the company's share price to reach $8.38 in the next year. This suggests a possible upside of 182.0% from the stock's current price.
View analysts price targets for SKIN
or view top-rated stocks among Wall Street analysts.

How have SKIN shares performed in 2023?

Beauty Health's stock was trading at $9.10 at the start of the year. Since then, SKIN stock has decreased by 67.4% and is now trading at $2.97.
View the best growth stocks for 2023 here
.

When is Beauty Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our SKIN earnings forecast
.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) issued its quarterly earnings data on Monday, November, 13th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. The firm had revenue of $97.40 million for the quarter, compared to analyst estimates of $115.96 million. Beauty Health had a negative net margin of 22.26% and a negative trailing twelve-month return on equity of 5.89%.

What ETF holds Beauty Health's stock ?

Ranger Equity Bear ETF holds 150,000 shares of SKIN stock, representing -1.00% of its portfolio.

What guidance has Beauty Health issued on next quarter's earnings?

Beauty Health updated its FY 2025 earnings guidance on Friday, September, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.00 million-$700.00 million.

Who are Beauty Health's major shareholders?

Beauty Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (15.00%), Senvest Management LLC (6.73%), Bamco Inc. NY (4.00%), Invesco Ltd. (1.49%), Wellington Management Group LLP (1.25%) and Braidwell LP (1.22%). Insiders that own company stock include Brent L Saunders, Doug K Schillinger and Michael P Monahan.
View institutional ownership trends
.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SKIN) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -